Hainan Shuangcheng Pharmaceuticals Co., Ltd. (SHE:002693)

China flag China · Delayed Price · Currency is CNY
8.58
-0.03 (-0.35%)
Apr 30, 2026, 3:04 PM CST
Market Cap3.56B -1.2%
Revenue (ttm)276.76M +58.9%
Net Income19.04M
EPS0.05
Shares Out414.69M
PE Ratio171.60
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume13,306,300
Average Volume11,857,051
Open8.57
Previous Close8.61
Day's Range8.43 - 8.74
52-Week Range6.36 - 9.52
Beta0.40
RSI54.32
Earnings DateApr 18, 2026

About SHE:002693

Hainan Shuangcheng Pharmaceuticals Co., Ltd. provides peptide, lyophilized, oncology, oral dosage, and other injection cartridge pharmaceutical products worldwide. The company offers thymalfasin, thymapentin, bortezmib, paclitaxel, somatostatin, pantoprazole, epifibatide, bivalirudin, liraglutide, and exenatide and sodium ferulate for injections, as well as vitamin B6. Hainan Shuangcheng Pharmaceuticals Co., Ltd. was founded in 2000 and is based in Haikou, the People’s Republic of China. [Read more]

Sector Healthcare
Founded 2000
Employees 605
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002693
Full Company Profile

Financial Performance

Financial Statements